Kevin S. Boyle Sr. - 16 Nov 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Chief Executive Officer, Director
Signature
/s/ Cyndi Baily, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
16 Nov 2021
Net transactions value
+$14,000
Form type
4
Filing time
17 Nov 2021, 15:53:45 UTC
Previous filing
31 Aug 2021
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Purchase $1,238 +884 +0.1% $1.40 875,884 16 Nov 2021 Direct
transaction TCRT Common Stock Purchase $12,762 +9,116 +1% $1.40 885,000 17 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.